141 related articles for article (PubMed ID: 35320850)
1. [Novel therapeutic approaches for salivary gland carcinomas].
Nachtsheim L; Prinz J; Arolt C; Quaas A; Meyer M; Klußmann JP; Wolber P
Laryngorhinootologie; 2022 Nov; 101(11):876-881. PubMed ID: 35320850
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract.
Locati LD; Cavalieri S; Bergamini C; Resteghini C; Alfieri S; Calareso G; Bossi P; Perrone F; Tamborini E; Quattrone P; Granata R; Galbiati D; Platini F; Orlandi E; Mariani L; Licitra L
Head Neck; 2019 Oct; 41(10):3670-3676. PubMed ID: 31355973
[TBL] [Abstract][Full Text] [Related]
3. AKT3 drives adenoid cystic carcinoma development in salivary glands.
Zboray K; Mohrherr J; Stiedl P; Pranz K; Wandruszka L; Grabner B; Eferl R; Moriggl R; Stoiber D; Sakamoto K; Wagner KU; Popper H; Casanova E; Moll HP
Cancer Med; 2018 Feb; 7(2):445-453. PubMed ID: 29282901
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy for salivary gland malignancy: current status and future perspectives.
Imamura Y; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Yokota T; Okano S; Tanaka K; Onoe T; Ariizumi Y; Homma A
Jpn J Clin Oncol; 2022 Apr; 52(4):293-302. PubMed ID: 35134985
[TBL] [Abstract][Full Text] [Related]
5. Systemic and Targeted Therapies in Adenoid Cystic Carcinoma.
Kacew AJ; Hanna GJ
Curr Treat Options Oncol; 2023 Jan; 24(1):45-60. PubMed ID: 36637743
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
Dodd RL; Slevin NJ
Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
[TBL] [Abstract][Full Text] [Related]
7. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
8. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
Marchiò C; Weigelt B; Reis-Filho JS
J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland cancers: biology and molecular targets for therapy.
Bell D; Hanna EY
Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of gefitinib in patients with advanced salivary gland cancers.
Jakob JA; Kies MS; Glisson BS; Kupferman ME; Liu DD; Lee JJ; El-Naggar AK; Gonzalez-Angulo AM; Blumenschein GR
Head Neck; 2015 May; 37(5):644-9. PubMed ID: 24585506
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features of lung salivary gland-type tumors].
Yan LM; Di JT; Nong L; Liang L; Wang W; Li X; Xiong Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):928-933. PubMed ID: 31818065
[No Abstract] [Full Text] [Related]
13. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients.
Couvreur K; Celine J; Marlies B; Randal D; Philippe D; Frederic D; Sylvie R
Acta Clin Belg; 2020 Oct; 75(5):362-369. PubMed ID: 31232197
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin therapy for adenoid cystic carcinoma.
Schramm VL; Srodes C; Myers EN
Arch Otolaryngol; 1981 Dec; 107(12):739-41. PubMed ID: 6274284
[TBL] [Abstract][Full Text] [Related]
18. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
[TBL] [Abstract][Full Text] [Related]
19. Management of minor salivary gland carcinomas.
Eschwege F
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):631-2. PubMed ID: 8655391
[No Abstract] [Full Text] [Related]
20. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy.
Liu H; Du L; Wang R; Wei C; Liu B; Zhu L; Liu P; Liu Q; Li J; Lu SL; Xiao J
Oncotarget; 2015 May; 6(13):11477-91. PubMed ID: 25909167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]